Pain control bandage now available for clinical use

April 09, 2003

Physicians can now prescribe a non-invasive, non-drug device to relieve certain types of pain. The CT1 Pain Control Bandage, approved by the Food and Drug Administration (FDA), relieves pain by electrically stimulating nerves through the skin, a technology known as transcutaneous electrical nerve stimulation (TENS).

The CT1 is small, wireless, and attaches directly to the affected area to provide pain relief. It has minimal side effects and offers an effective alternative to narcotics and other commonly used drugs in the treatment of some types of pain.

The CT1 has a wide range of possible uses, including alleviating pain from arthritis, bursitis, and traumatic injuries; treating minor cuts where regular bandages are applied; and alleviating the pain of minor surgical procedures such as suturing and arthroscopic surgery.

The device was developed by Cyclotec Medical Industries, Inc., in Lauderhill, Florida with support from NIDA's Small Business Innovation Research (SBIR) Program. Under this program, small businesses compete for grants to develop promising ideas that meet specific research and development needs of Federal agencies such as NIDA. The device won R&D Magazine's 2002 100 Award as the one of the 100 best new science and medical technologies of the year. The R&D 100 Award is one of the most prestigious honors in applied research, having previously been given to technological breakthroughs such as the printer, the fax, and the automatic teller machine.
The National Institute on Drug Abuse (NIDA) is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports more than 85 percent of the world's research on the health aspects of drug abuse and addiction. The Institute carries out a large variety of programs to ensure the rapid dissemination of research information and its implementation in policy and practice. Fact sheets on the health effects of drugs of abuse and other topics are available in English and Spanish. These fact sheets and further information on NIDA research and other activities can be found on the NIDA home page at

NIH/National Institute on Drug Abuse

Related Pain Articles from Brightsurf:

Pain researchers get a common language to describe pain
Pain researchers around the world have agreed to classify pain in the mouth, jaw and face according to the same system.

It's not just a pain in the head -- facial pain can be a symptom of headaches too
A new study finds that up to 10% of people with headaches also have facial pain.

New opioid speeds up recovery without increasing pain sensitivity or risk of chronic pain
A new type of non-addictive opioid developed by researchers at Tulane University and the Southeast Louisiana Veterans Health Care System accelerates recovery time from pain compared to morphine without increasing pain sensitivity, according to a new study published in the Journal of Neuroinflammation.

The insular cortex processes pain and drives learning from pain
Neuroscientists at EPFL have discovered an area of the brain, the insular cortex, that processes painful experiences and thereby drives learning from aversive events.

Pain, pain go away: new tools improve students' experience of school-based vaccines
Researchers at the University of Toronto and The Hospital for Sick Children (SickKids) have teamed up with educators, public health practitioners and grade seven students in Ontario to develop and implement a new approach to delivering school-based vaccines that improves student experience.

Pain sensitization increases risk of persistent knee pain
Becoming more sensitive to pain, or pain sensitization, is an important risk factor for developing persistent knee pain in osteoarthritis (OA), according to a new study by researchers from the Université de Montréal (UdeM) School of Rehabilitation and Hôpital Maisonneuve Rosemont Research Centre (CRHMR) in collaboration with researchers at Boston University School of Medicine (BUSM).

Becoming more sensitive to pain increases the risk of knee pain not going away
A new study by researchers in Montreal and Boston looks at the role that pain plays in osteoarthritis, a disease that affects over 300 million adults worldwide.

Pain disruption therapy treats source of chronic back pain
People with treatment-resistant back pain may get significant and lasting relief with dorsal root ganglion (DRG) stimulation therapy, an innovative treatment that short-circuits pain, suggests a study presented at the ANESTHESIOLOGY® 2018 annual meeting.

Sugar pills relieve pain for chronic pain patients
Someday doctors may prescribe sugar pills for certain chronic pain patients based on their brain anatomy and psychology.

Peripheral nerve block provides some with long-lasting pain relief for severe facial pain
A new study has shown that use of peripheral nerve blocks in the treatment of Trigeminal Neuralgia (TGN) may produce long-term pain relief.

Read More: Pain News and Pain Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to